Sitagliptin / Metformin hydrochloride Mylan Eiropas Savienība - latviešu - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - cukura diabēts, 2. tips - cukura diabēts - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , triple kombinēto terapiju), kā palīglīdzekli, lai diētu un vingrošanu pacientiem nepietiekami kontrolē par to maksimālā pieļaujama devu metformīns un sulfonilurīnvielas pamata. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Irbesartan Hydrochlorothiazide BMS Eiropas Savienība - latviešu - EMA (European Medicines Agency)

irbesartan hydrochlorothiazide bms

bristol-myers squibb pharma eeig - irbesartan, hydrochlorothiazide - hipertensija - agents, kas iedarbojas uz renīna-angiotenzīna sistēmu - esenciālas hipertensijas ārstēšana. Šī fiksētas devas kombinācija nav norādīts pieaugušiem pacientiem, kuru asinsspiedienu nevar pienācīgi kontrolēt par irbesartan vai hydrochlorothiazide atsevišķi (skatīt 5. iedaļu.

Vildagliptin / Metformin hydrochloride Accord Eiropas Savienība - latviešu - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - cukura diabēts, 2. tips - cukura diabēts - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 un 5. 1 pieejamo datu par dažādām kombinācijām).

Sitagliptin / Metformin hydrochloride Sun Eiropas Savienība - latviešu - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - cukura diabēts, 2. tips - cukura diabēts - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , triple kombinēto terapiju), kā palīglīdzekli, lai diētu un vingrošanu pacientiem nepietiekami kontrolē par to maksimālā pieļaujama devu metformīns un sulfonilurīnvielas pamata. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Valsartan/hydrochlorothiazide Krka 160 mg/25 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

valsartan/hydrochlorothiazide krka 160 mg/25 mg apvalkotās tabletes

krka, d.d., novo mesto, slovenia - valsartanum, hydrochlorothiazidum - apvalkotās tabletes - 160 mg/25 mg

Valsartan/hydrochlorothiazide Krka 80 mg/12,5 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

valsartan/hydrochlorothiazide krka 80 mg/12,5 mg apvalkotās tabletes

krka, d.d., novo mesto, slovenia - valsartanum, hydrochlorothiazidum - apvalkotās tabletes - 80 mg/12,5 mg

Valsartan/hydrochlorothiazide Krka 160 mg/12,5 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

valsartan/hydrochlorothiazide krka 160 mg/12,5 mg apvalkotās tabletes

krka, d.d., novo mesto, slovenia - valsartanum, hydrochlorothiazidum - apvalkotās tabletes - 160 mg/12,5 mg

Telmisartan/Hydrochlorothiazide TAD 40 mg/12,5 mg tabletes Latvija - latviešu - Zāļu valsts aģentūra

telmisartan/hydrochlorothiazide tad 40 mg/12,5 mg tabletes

tad pharma gmbh, germany - telmisartanum, hydrochlorothiazidum - tablete - 40 mg/12,5 mg

Telmisartan/Hydrochlorothiazide TAD 80 mg/25 mg tabletes Latvija - latviešu - Zāļu valsts aģentūra

telmisartan/hydrochlorothiazide tad 80 mg/25 mg tabletes

tad pharma gmbh, germany - telmisartanum, hydrochlorothiazidum - tablete - 80 mg/25 mg

Telmisartan/Hydrochlorothiazide TAD 80 mg/12,5 mg tabletes Latvija - latviešu - Zāļu valsts aģentūra

telmisartan/hydrochlorothiazide tad 80 mg/12,5 mg tabletes

tad pharma gmbh, germany - telmisartanum, hydrochlorothiazidum - tablete - 80 mg/12,5 mg